Combination of anti-HIV reverse transcriptase and protease inhibitors

Details for Australian Patent Application No. 2005261701 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Hoetelmans, Richard Marinus Wilhelmus

Agent Shelston IP

Pub. Number AU-A-2005261701

PCT Pub. Number WO2006/005720

Priority 04103256.6 08.07.04 EP

Filing date 8 July 2005

Wipo publication date 19 January 2006

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/7076 (2006.01)

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/005720 Priority application(s): WO2006/005720

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261702-Phosphated alcanol, its use as a hydrotrope and cleaning composition containing the compound

2005261699-Novel sequence for improving expression of nucleic acid